American Society of Hematology, Blood, 12(129), p. 1680-1684, 2017
DOI: 10.1182/blood-2016-07-723148
Full text: Download
Key Points CMV is prevalent in pretreatment bone marrow from childhood ALL and not in acute myeloid leukemia. In utero infection with CMV is a risk factor for ALL (OR = 3.71, P = .0016) and is more pronounced in Hispanics (OR = 5.90, P = .006).